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Introduction
Today
Large-scale genome sequencing is filling up the catalogue
of natural proteins at a breathtaking speed. Today, we
have available not just a large number of sequences, but
also glimpses of the inventory of entire organisms. This
information will soon improve our understanding of cells
and of life in general. Three means will contribute to this
expanding body of knowledge: sequencing genomes
(genomics); the determination of protein structures; and
the determination of protein function. Protein structure is
interwoven with function (e.g. [1–3]). Sequence analysis
and determination of function are also routinely combined
(e.g. [4]). What about the relationship between structure
determination and genomics, however?
Tomorrow
Structural genomics, the marriage between protein struc-
ture determination and genomics, is already beginning.
Attempts are made here to illustrate the likely direction
this marriage will take. Structure determination will be
pushed by, and profit from, genomics. Furthermore,
basing research and technical developments, such as
drug design, on all three pillars (sequence, structure and
function) will provide a large step towards the under-
standing of life. 
Objectives
Structure determination will benefit from genomics in two
ways (Figure 1). Firstly, the mass of available sequences
will facilitate the quick determination of structure for most
existing folds. Secondly, the availability of sequences for
the entire genome of an organism will not only help us to
unravel missing links in functional pathways, but also to
explore alternative pathways and to widen our understand-
ing of principle mechanisms and evolutionary cross-links. 
Genomics and structure: two flourishing fields 
The first sequence of an entire genome of an organism
was published in 1995. Two years on, another ten com-
plete genome sequences have been published (Table 1).
Nucleotide databases have increased two times more over
the last two years, than in the previous 20 years
(Figure 2). The growth of these databases now outpaces
even the development of computers (Figure 2). This is
merely the beginning.
Figure 1
Objectives for structure determination in the
era of genomics. (a) The first objective is to
utilise the mass of known protein sequences
to determine all natural folds. The ellipsoid
symbolises the universe of protein structures
and the islands symbolise existing structures
(or folds). Some of the islands are larger as
some folds occur more often (e.g. TIM barrel,
immunoglobulin-like, NTP hydrolase,
ferredoxin-like, Rossmann fold, globin-like,
flavodoxin-like and Ribonuclease H fold [15]).
The colour coding distinguishes three
situations: most structures are known (green);
some structures (i.e. the principle folds are
known; half green, half white); no structure is
known (white). (b) The second objective is to
utilise the entire genome sequences of
organisms to fill in the missing links in
pathways and mechanisms. The red circles
indicate sequence families (sequences within
a family have significant levels of pairwise
sequence identity), the solid arrows symbolise
a well known pathway in organism X
(Afi B fi Cfi D) and the dashed arrows
symbolise the analogous pathway in organism
Y (Afi B¢fi C¢fi D). If proteins B and C do not
exist in organism Y, this pathway cannot be
mapped from knowing all sequences of Y.
Imagine we know the structure of B, then
threading (fold recognition) may enable us to
deduce that B¢ adopts the role of B. Without
knowing the structures of C or C¢ , however,
we still could not guess the interaction partner
of B¢ , and thus still could not map the
pathway. Knowing structures for all sequence
families (all red circles) it would be possible to
easily find the pathway in Y.
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Structure determination has now become almost routine
[5]. Currently, as many structures are determined every
ten days as in the first ten years of crystallography
(Figure 2). Hitting on a novel fold, however, still resem-
bles unearthing a nugget [1,2]. Each novel fold can con-
tribute towards understanding the functional details of
entire protein families. How does the rate of determina-
tion of new structures compare to the rate of determina-
tion of sequence data? Considering the organisms for
which the entire genome sequence is known (Figure 3),
we have structural knowledge for one in every ten protein
sequences. Three projects have recently been initiated to
solve structures systematically for all the proteins within
an organism (http://www.mcs.anl.gov/home/gaasterl/sg-
review.html): Haemophilus influenzae (J Moult, Centre for
Advanced Research in Biotechnology [CARB], in collabo-
ration with the Institute for Genomic Research [TIGR]);
Pyrobaculum aerophilum (T Terwillinger, Lawrence Liver-
more National Laboratory [LANL]; D Eisenberg and J
Miller, University of California Los Angeles [UCLA]); and
Methanococcus jannaschii (S-H Kim, Lawrence Berkeley
National Laboratory [LBNL]). With all this wealth of infor-
mation, what are the objectives of structural genomics?
Using the mass of sequences to populate each island in
structure space
Filling the blank spots in structure space
Already we know approximately 500 [1] of the estimated
1000 protein folds [6,7]. Thus, only about half the ‘blank
spots’ in structure space remain to be filled (Figure 1a). Opti-
mistic or not, the first objective for structural genomics will
be to determine most water-soluble native folds. Genomics
can facilitate finding the blank spots. The recipe is simple:
find proteins common to different organisms; exclude those
with structural homologues (10%; Figure 3); exclude integral
membrane proteins (20–30%; Figure 4); and exclude all
proteins for which threading detects known folds (<10%)
[8,9]. Arriving at the final list requires a large repository of
sequences and some skills in bioinformatics. The mass of
sequences yielded by genomics will help surmount essential
problems in structure determination (e.g. protein expression,
purification, and — for crystallography — growth of crystals).
For each blank spot candidate, research groups can select the
homologue in their favourite organism, (e.g. from thermo-
philic bacteria, where proteins have the advantage of remain-
ing stable at high temperatures). How likely is a structure,
thus selected, to have a novel fold? Today, the specific goal
to find novel folds is not driving structure determination.
Nevertheless, 10–30% of the structures added to the Protein
Data Bank (PDB) constitute novel folds [1]. A large-scale
structure determination enterprise could easily yield 2000
(additional) new structures annually. Thus, we shall have at
least one representative structure for every fold in less than a
decade (assuming an initial 10% yield of novel folds, this
yield then decaying exponentially).
Adding details to the map
Most pairs of similar structures have <15% pairwise
sequence identity (Figure 5). Thus, filling all the blank
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Table 1
Completely sequenced genomes*.
Genome Date Reference
Haemophilus influenzae 8/95 [22]
Mycoplasma genitalium 10/95 [23]
Saccharomyces cerevisiae 1/96 [24]
Methanococcus jannaschii 8/96 [25]
Synechocystis sp. PCC6803 9/96 [26]
Mycoplasma pneumoniae 11/96 [27]
Escherichia coli 1/97 [28]
Methanobacterium thermoautotrophicum 5/97 [29]
Archaeoglobus fulgidus 6/97 [30]
Helicobacter pylori 6/97 [31]
Borrelia burgdorferi 7/97 [32]
Treponema pallidum 10/97 †
Bacillus subtilis 11/97 [33]
Pyrococcus horikoshii 1/98 ‡
Aquifex aeolicus 2/98 [34]
*List obtained from T Gaasterland,
http://www.mcs.anl.gov/home/gaasterl/genomes.html. †Sequences
publicly available (CM Fraser et al.). ‡Sequences partially publicly
available [35].
Figure 2
The rate of growth of databases of biomolecules. The explosion of
biomolecular data is illustrated by three representative databases: the
protein structure database PDB [16] (red line, circles); the protein
sequence database SWISS-PROT [17] (yellow line, triangles); and the
nucleotide sequence database EMBL [18] (blue line, diamonds). The
number of symbols (circles, triangles, diamonds) roughly reflects the
number of releases of the respective database. For comparison the
growth of computer speed is also shown (grey thin line; speed doubles
every 18 months). 
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Structure
spots does not yield all families populating the respective
island (Figure 1). The enormous sequence variation
within islands is often associated with functional diver-
gence (or convergence). In order to use structure determi-
nation to help further our understanding of protein
function, the next goal of structural genomics will be to
determine structures for all sequence families (and prefer-
ably for more than one representative per family). How
many structures would it take to fill the map with such
detail? Currently, the structures are known for 1145 pro-
teins of unique sequence (the set used in Figure 5) [10],
and these represent about 10% of known genomes
(Figure 3). Thus, about 10,000 additional structures are
required to provide one structure per sequence family).
This second phase, however, yields 100% coverage in a
large-scale structure determination project (the recipe
described above only selects candidates representing a
single sequence family). Thus, assuming a moderate pro-
duction of 2000 structures annually, approximately
twofold coverage should be obtained within a decade. 
Using the entirety of organisms to cover all functional
elements
Finding missing links in pathways
Knowing all the protein sequences for entire organisms,
we can start to map them to pathways (e.g. metabolic,
regulatory, signalling, pathogenic), or particular mecha-
nisms (e.g. expression, transcription, replication, recombi-
nation) [11]. Suppose we miss one (or a couple) of the
proteins essential for a particular pathway. Can we con-
clude that this pathway is missing in the organism, or
should we try harder to find it? The answer provides the
second objective for structural genomics: to find function-
ally missing links (Figure 1b). Initially this objective will
aim to determine the missing structures for all major path-
ways and mechanisms. The first step, to complete the
structural knowledge for all pathways and mechanisms for
which we know the associated proteins, is straightforward.
The second step, however, appears hopeless: how can we
determine structures for unknown proteins? In reality this
may not prove to be as difficult as it would at first seem. It
is likely that many of the candidates selected to find all
the blank spots in structural space will turn out to be rep-
resentatives of most major functional protein classes. In
addition, in the course of large-scale structure determina-
tion, cross-links will be uncovered that complete the cata-
logue of proteins participating in certain functions 
(e.g. the corresponding mechanisms identified in fragile
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Figure 3
Percentage of proteins in genomes with homologues of known
structure. For nine whole genomes, the figure shows the number of
proteins for which a sequence homologue of known structure exists in
the PDB as a percentage of all identified proteins (the total numbers of
proteins used are written on the bars). The genomes of eukaryotes are
shown in blue, prokaryotes are in green, and archae are in red. For
about 80% of the proteins considered here, the structure is inferred by
homology modelling [19]. In addition, the estimates are conservative in
that high homology thresholds have been applied. Homologues
inferred by threading methods were not considered.
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Figure 4
The percentage of helical transmembrane proteins in organisms. For
the first four genomes to be entirely sequenced the percentage of
proteins from the genome predicted by PHD topology [20] to have
helical membrane regions is shown. The four organisms are colour-
coded: mj, Methanococcus jannaschii (yellow); mg, Mycoplasma
genitalium (purple); sc, Saccharomyces cerevisiae (blue); hi,
Haemophilus influenzae (magenta). The horizontal axis gives the
number of transmembrane helices predicted; the vertical axis gives the
cumulative percentage of proteins in the genome. For example, about
25% of the proteins of H. influenzae and S. cerevisiae are predicted to
have at least one transmembrane helix; 7% of the proteins of H.
influenzae and 5% of the proteins of S. cerevisiae are predicted to
contain seven or more transmembrane helices. (A list of the proteins is
available at: http://www.embl-heidelberg.de/~rost). 
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Structure
histidine triad protein (FHIT) and protein kinase C
interacting protein (PKCI) and the implications of their
structural similarity to galactose-1-phosphate uridylyl-
transferase (GalT) [3]). 
Filling function space
After determining structures for all major functional
elements, we shall have to complete the functional map
(i.e. it will be necessary to determine structures for repre-
sentatives of all pathways and mechanisms). Candidates
for those structures to be determined will be found by
structure-based comparative genome analysis, focusing on
particular sites (e.g. active sites and binding sites) or
uncovering ‘motifs’ [1]. For example, the goal could be to
find the scaffold containing the common features of all
amino hydrolases [12]. Furthermore, alternative pathways
will be searched, as well as proteins with particular
biochemical ‘fingerprints’ (the structures of such proteins
will be crucial to correctly define the motifs). Finally,
unknown functions could be searched for specifically by
classifying families of determined and homology-
modelled structures into functional groups based on
electrostatic properties [13], or based on simple combina-
tions of sequence alignment and structure analysis [14]. 
Conclusions
Profiting from mass and entirety
The major objectives of structural genomics have been
portrayed here: to find all natural structures; and to find
missing links in all functional pathways and mechanisms
(Figure 1). These objectives correspond to two aspects of
genome sequencing: the mass of sequences produced; and
the entirety of sequencing complete genomes from organ-
isms. In order to attain the objectives outlined here a
large-scale structure determination enterprise is required. 
What will come out?
A prerequisite for understanding the function of a protein is
to know its structure. Furthermore, large-scale structure
determination will enable us to uncover most major func-
tional elements. The scaffolds of structures provide the ele-
ments for evolution. Most functional motifs known today
are sequence motifs. In the absence of structural data,
however, most functional motifs remain hidden. Structural
genomics will help us to further understand evolution, and
will also provide the knowledge necessary to improve the
techniques used in processes such as drug design and dis-
covery. Finally, entities defined by refined structural [8,15]
and functional features [1,2] will permit a more elaborate
comparison of organisms than sequence analysis. 
What will not come out?
This review has focused on the description of structural
modules, or domains. Clearly, domains are not enough to
understand function. Instead, we need to study functional
complexes composed of many proteins. Although a large-
scale structure determination enterprise may trigger the
study of such complexes by uncovering their elements, a
comprehensive exploration of functional systems will be
the next step. 
When will we get there?
Humans have about 100,000 different proteins. If we
knew all these sequences today, through a combination of
structure determination and prediction we would already
have structural knowledge for more than 10,000 of these
(Figure 3). The sequence of the human genome, however,
will not be completed before the year 2004. With 2000
new structures determined by a large-scale enterprise, we
shall have structural knowledge for about 70% of all
human sequences by the year 2004; many of the remain-
ing 30,000 will be membrane proteins (Figure 4). 
Reality or dream?
The mass of sequences produced by genomics should
enable most natural folds to be determined within less than
a decade. Is this wishful thinking? Firstly, the — strongly
disputed — assumption that there are only 1000 folds is not
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Figure 5
The evolution of protein structures into the ‘midnight zone’ of sequence
identity. Proteins have evolved into the midnight zone of sequence
identity (i.e. into a region where sequence comparisons fail completely
to detect structural similarity [21]). The figure shows the distribution of
pairwise sequence identity for structurally aligned protein pairs (full line).
The average pairwise sequence identity of all remotely structurally
similar pairs (<25% sequence identity; left panel) is below 10%. To
reduce database bias, results displayed in the left panel are based on a
smaller data set (aligning 1145 structures of unique sequence against
themselves) than those displayed in the right panel (aligning 1145
sequences against the entire PDB). Consequently, numbers in the right
panel should be scaled down. To obtain a perspective less biased by
the choice of proteins for which structures are determined, numbers are
also given for a subset of SWISS-PROT for which homology modelling
is applicable (dashed line on right panel; aligning 1145 structures of
unique sequence against the entire SWISS-PROT database). 
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crucial. Instead, the upper limit for the number is provided
by the number of sequence families, and the estimate that
there are 10,000–15,000 families is rather conservative (to
date 1200 sequence families are known, corresponding to
8–18% of all families; Figure 3). To determine one structure
for each family is just a matter of a large-scale structure
determination enterprise. Secondly, 2000 structures were
added to the PDB in 1997, and structure determination
techniques continue to improve. Thus, the assumption that
2000 new structures will be determined annually is a rather
conservative estimate. What remains is the uncertainty as to
how difficult the unknown folds will be to determine. Here
we can only be guided by past experience, which shows
that most structure determination problems can be
solved — eventually. Of course there is no easy answer, we
just have to try. 
Supplementary material
Supplementary material available with the internet
version of this paper contains a diagram showing the per-
centage of protein structures annually deposited in the
PDB from a particular organism.
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